id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0022-0026,FDA,FDA-1978-N-0022,Letter from the Consumer Healthcare Products Association (CHPA) to FDA/DDM,Other,Letter(s),2012-03-06T05:00:00Z,2012,3,2012-03-06T05:00:00Z,,2020-04-13T15:30:43Z,,0,0,0900006480fcffbf
FDA-1978-N-0022-0027,FDA,FDA-1978-N-0022,Attachment A - Adverse Events Reported to Manufacturers of OTC External Analgesic Patch Products July 2009 through April 2011 re: Letter from the Consumer Healthcare Products Association (CHPA) to FDA/DDM,Supporting & Related Material,Background Material,2012-03-06T05:00:00Z,2012,3,,,2020-04-13T15:33:05Z,,0,0,0900006480fcffc1